by ODWAdmin | Sep 8, 2025
Combining Metabolomics, Proteomics and Transcriptomics to Reveal Key Pathways and Biomarkers Explore how reduced KRAS activity reshapes gene expression and pathway activity in HCT-116 cells. In this application note, Panome Bio combines next-generation metabolomics,...
by ODWAdmin | Sep 6, 2025
TissueBridge™ Metabolomics | A Validated Workflow for FFPE Tissue Panome Bio is excited to announce a new, fully validated service that brings comprehensive, untargeted metabolomics to formalin-fixed paraffin-embedded (FFPE) samples, TissueBridge Metabolomics....
by ODWAdmin | Sep 2, 2025
Metabolomics for Mechanism of Action: Understanding Drivers of Synergistic Inhibitor Treatment in Cancer Next-Generation Metabolomics can provide robust, biologically meaningful data for drug combination analysis. Learn more about treatment-induced metabolic...
by ODWAdmin | May 28, 2025
Next-Generation® Metabolomics for Dried Blood Spot Analysis Next-Generation Metabolomics can provide robust, biologically meaningful data for dried blood spot analysis. Learn more about the coverage, stability and concordance of Panome Bio’s methods in this...
by ODWAdmin | Jan 22, 2025
Panome Bio Provides Advanced Microbiome Analysis with Next-Generation Metabolomics – Deepen Insights with Bile Acids, SCFAs, & More This application note provides a high level look at how Panome Bio’s Microbiome Function Analysis suite of services...
